Available IPD datapackage for study 'A Randomized, Open-Label, Parallel-Arm, Noninferiority Comparison of the Effects of Two Doses of LY2189265 and Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes on Stable Doses of Metformin and Glimepiride'

The purpose of this study is to determine if LY2189265 is effective in reducing hemoglobin A1c (HbA1c) and safe, as compared to Insulin Glargine in participants with Type 2 Diabetes. Participants must also be taking metformin and glimepiride.

本研究旨在探究LY2189265相较于甘精胰岛素（Insulin Glargine），在同时服用二甲双胍（metformin）与格列美脲（glimepiride）的2型糖尿病（Type 2 Diabetes）受试者中，降低糖化血红蛋白（Hemoglobin A1c，HbA1c）的有效性与安全性。